## Abstract __MLL__ (also known as __ALL‐1, HTRX__, or __HRX__) gene translocations are among the most common chromosomal abnormalities recognized in both B‐lineage acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). However, __MLL__ gene rearrangements are uncommon in T‐cell ALL.
T-cell lineage acute lymphoblastic leukemia with chromosome 5 abnormality in a patient with Crohn's disease and lipoid nephrosis
✍ Scribed by L. Pérard; X. Thomas; H. Jaumain; G. Theuil; M. Bret; B. Coronel; C. Charrin; P. Boulétreau
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 199 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To the Editor: Immunomodulatory therapies such as 6-mercaptopurine (6-MP) and azathioprine provide high remission rates and success in avoiding steroid dependence in patients with inflammatory bowel disease (IBD). However, these treatments are not without adverse effects including leukopenia, liver
TAL1 gene deregulation is frequent in T-cell acute lymphoblastic leukemia (T-ALL) and can result from translocations involving 1p32 or, more frequently, from a cytogenetically undetectable interstitial deletion of chromosome 1. This study presents a case of T-ALL with a t(1;5)(p32;q31) involving TAL
## Abstract __AML1__ is among the most frequent targets of chromosomal rearrangements in human leukemias. We report here the molecular analysis of a t(4;21)(q28;q22) that has disrupted __AML1__ in a patient with de novo T‐cell acute lymphoblastic leukemia. By using 3′‐RACE analysis, we show that th
## Abstract Cytogenetic studies on primary material and established cell lines of a patient with B‐cell non‐Hodgkin Lymphoma with leukemic presentation as secondary malignancy after Hodgkin's disease clearly revealed correspondent marker chromosomes in both culture systems. A translocation t(8;22)